Benralizumab vs Gefitinib

## Benralizumab vs Gefitinib: Overview

This comparison examines the pharmacological differences between **Benralizumab** and **Gefitinib**.

## Mechanism of Action

**Gefitinib**: Selective reversible inhibitor of EGFR tyrosine kinase.

## Pharmacokinetics

**Half-life**: Benralizumab — N/A; Gefitinib — 48 hours.

## Chemical Properties

**Molecular Formula**: Benralizumab — N/A; Gefitinib — C22H24ClFN4O3.

**Molecular Weight**: Benralizumab — N/A; Gefitinib — 446.9000 g/mol.

**Type**: Benralizumab — Antibody; Gefitinib — Small molecule.